Feds Set to Split Anti-Drug Media Review Into $150 Mil. 'Phase II,' $195 Mil. 'Phase III'

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.




WASHINGTON, D.C.-The Office of National Drug Control Policy (ONDCP) here is close to issuing two requests for additional components in its $1 billion anti-drug media review.
The first of the two, which should be available next week, will be a limited competition for an agency to perform media placement for the client’s $150 million national rollout. Called “Phase II,” the initiative will run from May to October. The review will probably be limited to agencies with solid government experience, ONDCP officials said.
The second rfp will involve an open competition for “Phase III,” a four-year contract for media placement that will be negotiated to the tune of a $195 million annual budget.




AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in